Time to first-line chemotherapy and travel distance to the cancer center and their relationship to subsequent-line therapies in stage IV CRC.
Mahjabeen Fatima Iqbal(King's College London), Shahid Ahmed(Emory University), Nayyer Iqbal(University of Saskatchewan), Kamal Haider(University of Saskatchewan), Adnan Zaidi(University of Saskatchewan), Tahir Abbas(University of Saskatchewan), Aleksi Suo(University of Saskatchewan), Neha Papneja(McGill University)
Cited by 0
Related Papers
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
HER2-directed therapy: current treatment options for HER2-positive breast cancer
|Breast Cancer|2015|183
Diabetes and Cancer: Risk, Challenges, Management and Outcomes
|Cancers|2021|183
Current status of immunotherapy in metastatic colorectal cancer
|International Journal of Colorectal Disease|2018|149